mutations and sophisticated kar yotype. It follows a linear evolution from your CLL clone with the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding regions with the genome, are mostly situated in Energetic promoters or enhancers, and modify the binding sites of a variety of transcription a